Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Bullboard (CSE:INNO)

View:
1 2 3 4 Next
Post by stocksavvy2000on Nov 18, 2024 2:33pm

positive FDA engagement

I like this company, I think there can be multiple revenue streams from the LPT-CBD
38
Post by realistic25on Oct 12, 2024 3:41pm

Excellente opportunité pour investisseur

Derniere nouvelle: https://www.medicaldaily.com/professor-chezy-barenholz-cbd-powered-revolution-pharmaceuticals-466088
70
Post by realistic25on Oct 12, 2024 3:26pm

An investor's opportunity in injectable liposomal CBD's pote

LOOK : https://stockhouse.com/news/newswire/2024/10/10/an-investor-s-opportunity-injectable-liposomal-cbd-s-potential
75
Post by Betteryear2on Sep 03, 2024 9:28pm

Advances Liposomal CBD with Positive Response from FDA

HERZLIYA, Israel and CALGARY, Alberta, Sept. 3, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company") ...more  
331
Post by Betteryear2on Aug 25, 2023 6:59pm

Innocan Pharma Reports Q2 2023 Results

US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compared to USD 214,000 for ...more  
242
Comment by Betteryear2on Jul 25, 2023 8:53pm

RE: Private Placement of Units at a 9% Prime Above Share Price

Note: There appears to be an error in release. It states: The Offering is expected to close on or around July 20, 2023. The reader should also be aware that it has not yet been posted in ...more  
180
Discussion
Post by Betteryear2on Jul 25, 2023 8:46pm

Private Placement of Units at a 9% Prime Above Share Price

HERZLIYA, Israel, and CALGARY, Alberta, July 25, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan ...more  
220
Discussion
Post by Betteryear2on Apr 29, 2022 9:03am

Innocan Pharma's Compassionate Care Treatment for Dogs

A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ...more  
275
Post by Betteryear2on Apr 11, 2022 4:04pm

Innocan Pharma's Case Report Accepted

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased ...more  
249
Post by Betteryear2on Jan 17, 2022 4:13pm

Inauguration of Its Drug Development Lab

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is ...more  
327
Post by dkeller85on Jan 11, 2022 8:33am

Why this Canadian-Israeli Stock Grew 121% This Year

"Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale ...more  
305
Post by Charly50on Nov 24, 2021 12:19pm

Distributers and investors

Our CEO Iris Bincovich reports back from Canada. She achieved: Meetings and soft commitments from distributers and investors and positivite feedbacks from pharma experts. More to follow soon via ...more  
279
Post by Betteryear2on Nov 18, 2021 4:31pm

Successful Demonstration of Prolonged Release of CBD in Dogs

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is ...more  
290
Post by Charly50on Nov 17, 2021 12:50pm

https://www.wallstreet-online.de/nachricht/14682875-innocan-

Innocan Pharma wird auf der Lift & Co. Expo am 19. November 2021 an einer Podiumsdiskussion zum Thema Unternehmenswachstum teilnehmen
184
1 2 3 4 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities